Get the Prostate Cancer Patient Guide, available as a free emailed pdf.

Go here to learn more or to get a mailed copy.

Session 1: Novel Clinical Trial Updates

Session 1: Novel Clinical Trial Updates
29th Annual PCF Scientific Retreat: October 27, 2022 | 1:05 PM – 2:25 PM

Moderator: Jake Vinson, MHA
The Prostate Cancer Clinical Trials Consortium

Targeting a Tumor-Specific CD46 Epitope in Metastatic Castration Resistant Prostate Cancer
Rahul Aggarwal, MD
University of California, San Francisco

Targeting Myeloid Chemotaxis via CXCR2 Blockade as a Therapeutic Strategy in Advanced Prostate Cancer
Christina Guo, MD
Institute for Cancer Research; Royal Marsden Hospital, UK

Biomarker Results from Targeting TROP2 with Sacituzumab Govitecan in mCRPC
Joshua Lang, MD
University of Wisconsin

TRITON3: A Phase 3 Study of Rucaparib vs. Physician’s Choice of Therapy in mCRPC associated with HRD
Alan Bryce, MD
Mayo Clinic

80 cents of every dollar donated goes to our prostate cancer research mission

Join the fight against prostate cancer today. Donate